go back

Dolasetron, Oral

Maryland rates for HCPCS Q0180

Dolasetron mesylate, 100 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 24-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $62 · 10th–90th $60$620%50%100%10th$62Professionalmedian $60 · 10th–90th $56$620%50%10th90th$60$50.0$100.0$200.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$61.66
Median
$61.66
Typical High
$61.66
Aetna
Setting
Professional
Modifier
Global
Typical Low
$57.54
Median
$60.26
Typical High
$61.66
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$56.23
Median
$56.23
Typical High
$56.23
Cigna
Setting
Professional
Modifier
Global
Typical Low
$61.66
Median
$61.66
Typical High
$61.66
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$52.48
Median
$67.61
Typical High
$93.33
United
Setting
Facility
Modifier
Global
Typical Low
$60.26
Median
$60.26
Typical High
$60.26
United
Setting
Professional
Modifier
Global
Typical Low
$60.26
Median
$60.26
Typical High
$97.72
Wellpoint
Setting
Professional
Modifier
Global
Typical Low
$95.50
Median
$95.50
Typical High
$95.50